This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Rafnsson, S. B Articles by Fowkes, F. PubMed PubMed Citation Articles by Rafnsson, S. B Articles by Fowkes, F. Social Bookmarking                   What's this?

Peripheral arterial disease and cognitive function

Public Health Sciences Section, School of Clinical Sciences and Community Health, University of Edinburgh, Edinburgh, Scotland S.B.Rafnsson{at}ed.ac.uk

Ian J Deary

Department of Psychology, School of Philosophy, Psychology and Language Sciences, University of Edinburgh, Edinburgh, Scotland

FGR Fowkes

Public Health Sciences Section, School of Clinical Sciences and Community Health, University of Edinburgh, Edinburgh, Scotland

Abstract

As a marker of generalized atherosclerosis, peripheral arterial disease (PAD) has implications not only for the affected lower extremity but also to overall cardiovascular health. It confers an increased risk of non-fatal and fatal vascular events which increases with the severity of the disease. Patient-based studies have shown that individuals with advanced PAD tend to perform poorly on cognitive tests compared to controls. In population studies, PAD is associated with an increased cognitive decline independently of previous cerebrovascular disease and cardiovascular risk factors. A low ankle–brachial index (ABI) may be an early predictor of cognitive decline and of potential value in identifying individuals at increased risk of cognitive impairment. In patients with PAD, secondary preventive measures directed at decreasing the long-term systemic vascular complications may also be important to the preservation of cognitive health. However, evidence suggests that PAD patients may be undertreated with regard to atherosclerotic risk factors, as demonstrated by an undue emphasis on symptom relief rather than essential risk factor reduction. More research needs to be carried out to determine the predictors of cognitive function in PAD patients, whether subtle cognitive disturbances are related to activities of daily living, including medical treatment compliance, and whether neuroprotective strategies and atherosclerotic risk factor control positively influence cognitive function in these high-risk patients.

Key Words: cognition • ankle–brachial index • intermittent claudication • peripheral arterial disease

Vascular Medicine, Vol. 14, No. 1, 51-61 (2009)
DOI: 10.1177/1358863X08095027


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?